• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Lithium Exposure In Utero—How Bad Is It Really?

Lithium Exposure In Utero—How Bad Is It Really?

July 1, 2022
Victoria Hendrick, MD and Lara Tang, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Lara Tang, MD, and Victoria Hendrick, MD. Dr. Tang and Dr. Hendrick have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

REVIEW OF: Fornaro M et al, Am J Psychiatry 2020;177(1):76–92

STUDY TYPE: Literature review

Most of us are wary of prescribing lithium to pregnant patients, but is prenatal lithium exposure as risky as we think? A meta-analysis of 13 case-control, cohort, and interventional studies (n = 1,349,563 pregnancies) compared congenital anomalies among lithium-exposed and unexposed mothers with and without bipolar disorder (BD).

Lithium use at any time in pregnancy, compared with unexposed women (either with BD or general population controls), was associated with a significantly elevated risk of congenital and cardiac anomalies (odds ratio [OR] 1.75, p < 0.01 and OR 1.9, p < 0.01, respectively)—and the risk was even higher if lithium was used in the first trimester. However, in their discussion, the authors point out that the absolute risks are low: 4.2% for any malformations and 1.2% for cardiac malformations. First-trimester lithium exposure was also linked with a higher risk of spontaneous abortion (OR 3.8, p = 0.03)—but this risk was about the same in pregnant patients with mood disorders not on lithium. This suggests that the underlying mood disorder contributes to the risk of spontaneous abortion.

Compared to no lithium use, lithium use was significantly more effective in preventing a mood relapse in the postpartum (OR 0.16, p = 0.12). The rate of cardiac malformations tripled with dosages above 900 mg/day when compared with dosages under 600 mg/day and maternal lithium levels < 0.64 mEq/L. At these lower doses, the risk of cardiac malformations was comparable to that of unexposed newborns. Also, infants exposed to lower lithium doses were more reactive. The authors point out several limitations in their data, including a lack of information on other prescribed medications besides lithium.

CARLAT TAKE

Lithium use during pregnancy, especially in the first trimester, elevates the risks of congenital and cardiac anomalies, but it also helps prevent postpartum mood relapses. The absolute risk for congenital issues remains low—and you can reduce this risk further by keeping the lithium dose below 600 mg/day and the maternal lithium levels below 0.64 mEq/L. However, some patients, especially those with severe illness, may require higher lithium concentrations to remain stable. While this study has methodologic limitations typically inherent in research on prenatal psychotropic medication exposures, it provides helpful guidelines for the use of lithium in pregnant patients.

KEYWORDS bipolar lithium postpartum depression pregnancy
    Tcr 2005 10 qa victoria hendrick 150x150
    Victoria Hendrick, MD

    Hospital Psychiatry Fact Book, First Edition (2025)

    More from this author
    Lara Tang, MD

    How Long to Wait Before Changing Antipsychotics in Schizophrenia?

    More from this author
    www.thecarlatreport.com
    Issue Date: July 1, 2022
    SUBSCRIBE NOW
    Table Of Contents
    Psychiatric Medication–Induced Hyperprolactinemia
    Minimizing the Use of Seclusion and Restraints
    Treating Common Medical Conditions in Patients With Chronic Mental Illnesses
    EmPATH Units: An Innovative Approach to Mental Health Crises
    Lithium Exposure In Utero—How Bad Is It Really?
    Antidepressants for Suicidal Ideation in Depressed Patients?
    CME Post-Test - Minimizing Use of Restraints, CHPR, July/August/September 2022
    DOWNLOAD NOW
    Featured Book
    • HospPsychiatry_Spiral_Binding_Sm.png

      Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

      This comprehensive guide is designed to be a valuable resource for professionals working in...
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.